Shefferman Jesse 4
4 · Protara Therapeutics, Inc. · Filed Jan 7, 2025
Insider Transaction Report
Form 4
Shefferman Jesse
DirectorCEO and President
Transactions
- Tax Payment
Common Stock
2025-01-03$6.14/sh−6,479$39,781→ 929,022 total
Footnotes (1)
- [F1]Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 3, 2022.